Cargando…

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients

Detalles Bibliográficos
Autores principales:	Hall, Victoria G., Ferreira, Victor H., Ku, Terrance, Ierullo, Matthew, Majchrzak-Kita, Beata, Chaparro, Cecilia, Selzner, Nazia, Schiff, Jeffrey, McDonald, Michael, Tomlinson, George, Kulasingam, Vathany, Kumar, Deepali, Humar, Atul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385563/ https://www.ncbi.nlm.nih.gov/pubmed/34379917 http://dx.doi.org/10.1056/NEJMc2111462

Ejemplares similares

Paucisymptomatic COVID-19 in lung transplant recipient following two doses of mRNA-1273 (Moderna) vaccine
por: Marinelli, Tina, et al.
Publicado: (2021)

Safety and Immunogenicity After a Three-Dose SARS-CoV-2 Vaccine Schedule in Allogeneic Stem Cell Transplant Recipients
por: Kimura, Muneyoshi, et al.
Publicado: (2022)

Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings
por: Ferreira, Victor H., et al.
Publicado: (2022)

Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center
por: Ferreira, Victor H., et al.
Publicado: (2021)

Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study
por: Kabbani, Dima, et al.
Publicado: (2023)

Impact of Omicron BA.1 infection on BA.4/5 immunity in transplant recipients
por: Ferreira, Victor H., et al.
Publicado: (2023)

T-cell responses following Natural Influenza Infection or Vaccination in Solid Organ Transplant Recipients
por: L’Huillier, Arnaud G., et al.
Publicado: (2020)

Differential serum neutralisation of omicron sublineages in patients receiving prophylaxis with tixagevimab–cilgavimab
por: Solera, Javier T, et al.
Publicado: (2023)

Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
por: Solera, Javier T, et al.
Publicado: (2023)

Chronic Candida dubliniensis meningitis in a lung transplant recipient
por: Herrera, Sabina, et al.
Publicado: (2019)

Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in liver transplant recipients
por: Herrán, Aitor Odriozola, et al.
Publicado: (2022)

Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide
por: Straus, Walter, et al.
Publicado: (2022)

Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
por: Yamada, Takayuki
Publicado: (2023)

A Randomized Trial of High-dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients
por: Natori, Yoichiro, et al.
Publicado: (2017)

Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients
por: Giuliano, Anna, et al.
Publicado: (2023)

Assessment of Adenovirus Infection in Adult Lung Transplant Recipients Using Molecular Surveillance
por: Humar, Atul, et al.
Publicado: (2006)

Myocarditis After the Third Dose of mRNA-1273 Coronavirus Disease 2019 (COVID-19) Vaccine
por: Kawahara, Hiroshi, et al.
Publicado: (2022)

Ulcerative injection site reaction after third COVID‐19 vaccine dose with mRNA‐1273
por: Barei, Francesca, et al.
Publicado: (2022)

A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
por: Pettini, Elena, et al.
Publicado: (2022)

Life-Threatening Infection in Transplant Recipients
por: O’Shea, Daire T., et al.
Publicado: (2013)

Fascin-1 is a novel biomarker of aggressiveness in some carcinomas
por: Kulasingam, Vathany, et al.
Publicado: (2013)

Genomic profiling for copy number changes in plasma of ovarian cancer patients – a new era for cancer diagnostics?
por: Kulasingam, Vathany, et al.
Publicado: (2016)

Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine
por: Matsumoto, Naomi, et al.
Publicado: (2022)

Respiratory Viral Infections in Transplant and Oncology Patients
por: Kumar, Deepali, et al.
Publicado: (2010)

Ex-vivo delivery of monoclonal antibody (Rituximab) to treat human donor lungs prior to transplantation
por: Ku, Terrance J.Y., et al.
Publicado: (2020)

Long Term Immune Responses to Pandemic Influenza A/H1N1 Infection in Solid Organ Transplant Recipients
por: Baluch, Aliyah, et al.
Publicado: (2011)

mRNA-1273: Myocarditis: case report
Publicado: (2021)

mrna-1273: Erythema nodosum: case report
Publicado: (2021)

mrna-1273: Immediate hypersensitivity: case report
Publicado: (2021)

mrna-1273: Acute myocarditis: case report
Publicado: (2021)

mRNA-1273: Myopericarditis: case report
Publicado: (2021)

mRNA 1273: Anaphylaxis: case report
Publicado: (2021)

mrna-1273: Haematuria: 2 case reports
Publicado: (2021)

Quantitative Measurement of Anti-SARS-CoV-2 Antibodies: Analytical and Clinical Evaluation
por: Higgins, Victoria, et al.
Publicado: (2021)

Towards personalized tumor markers
por: Kulasingam, Vathany, et al.
Publicado: (2017)

Heterologous Ad.26.COV2.S versus homologous BNT162b2/mRNA-1273 as a third dose in solid organ transplant recipients seronegative after two-dose mRNA vaccination
por: Chiang, Teresa PY, et al.
Publicado: (2022)

Comparison of mRNA-1273 and BNT162b2 SARS-CoV-2 mRNA Vaccine Immunogenicity in Kidney Transplant Recipients
por: Haller, Maria C., et al.
Publicado: (2022)

mRNA-1273: Various toxicities: case report
Publicado: (2021)

mrna-1273/tozinameran: Myocarditis: 8 case reports
Publicado: (2021)

mrna-1273: Minimal change disease: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ilvua87mie2v9t8htf66t5flt6